文献速递产科母胎医学

已知或疑似胎盘植入谱系疾病计划性保守管理与剖宫产子宫切除术的成本效果分析

Intended Conservative Management Versus Caesarean Hysterectomy for Known or Suspected Placenta Accreta Spectrum: A Cost-Effectiveness Analysis.
PubMed 文献 · BJOG · 2024-12-05

该成本效果分析基于1000例>20周妊娠的胎盘植入谱系疾病(PAS)理论队列,比较保守管理(CM)与计划性剖宫产子宫切除术(CH)。基础病例中CM为节约成本策略,ICER为9330.51美元;概率敏感性分析中CM在71%的运行中具成本效果,42%的运行中占优。模型显示两种策略比较效果存在显著不确定性,需前瞻性研究评估CM效果。

要点

  • 基础病例分析中CM为节约成本策略,ICER为9330.51美元。
  • 与CH相比,CM减少905例子宫切除术、80例手术部位感染和5例死亡。
  • CM增加149例住院时间>5天和25例ICU入住;概率敏感性分析中CM在71%运行中具成本效果。

核心结论

  • CM在模型超过70%的迭代中为PAS管理的成本效果策略。
  • 模型显示两种策略比较效果存在显著不确定性,需前瞻性研究评估CM效果。

研究设计与样本

  • 成本效果分析,采用决策分析模型,理论队列为1000例>20周妊娠的PAS孕妇。
  • 基础病例分析假设20%至40%的个体符合CM条件,模型输入来自文献,从医疗系统角度进行1年分析。
  • 结局包括子宫切除术、手术部位感染(SSI)、住院时间、ICU入住和死亡;成本效果阈值定义为每质量调整生命年(QALY)50000美元。

主要发现

  • 基础病例估计中CM为节约成本策略,ICER为9330.51美元。
  • 与CH相比,CM减少905例子宫切除术、80例SSI和5例死亡。
  • CM增加149例住院时间>5天和25例ICU入住。
  • 概率敏感性分析中CM在71%的运行中具成本效果,在42%的运行中占优。

关键数值与推荐

  • 成本效果阈值:ICER为每QALY 50000美元。
  • 基础病例CM的ICER为9330.51美元。
  • 概率敏感性分析:CM在71%的运行中具成本效果,42%的运行中占优。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 模型显示两种策略比较效果存在显著不确定性,需前瞻性研究评估CM效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined the cost-effectiveness of conservative management (CM) compared to planned caesarean hysterectomy (CH) for placenta accreta spectrum (PAS). DESIGN: A cost-effectiveness analysis in a theoretical cohort of patients. SETTING: A decision analytic model. POPULATION: A theoretical cohort of 1000 pregnant patients with PAS greater than 20 weeks gestation. METHODS: In base case analysis, we assumed that between 20% and 40% of individuals would be eligible for CM. Model inputs were derived from the literature. Analysis was conducted from a healthcare system perspective with a 1 year analytic horizon. Outcomes included hysterectomy, surgical site infection (SSI), length of hospitalisation, intensive care unit (ICU) admission and death. An incremental cost-effectiveness ratio (ICER) of $50 000 per quality-adjusted life year (QALY) defined cost-effectiveness. Sensitivity analyses were performed. MAIN OUTCOME MEASURES: The cost gained per life year and per QALY. RESULTS: For base case estimates, CM was the cost-saving strategy with an ICER of $9330.51 USD. Compared to CH, CM resulted in 905 fewer hysterectomies, 80 fewer instances of SSI and five fewer deaths. CM resulted in 149 more admissions with length of stay > 5 days and 25 more ICU admissions. In probabilistic sensitivity analysis, CM was the cost-effective strategy in 71% of runs and the dominant strategy in 42% of runs. CONCLUSIONS: CM was the cost-effective strategy for the management of PAS in greater than 70% of iterations of our model. Modelling demonstrated significant uncertainty in the comparative effectiveness of the two strategies, highlighting the need for prospective research evaluating the effectiveness of CM.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Morgan JC, Hripko EN, Einerson BD, et al. Intended Conservative Management Versus Caesarean Hysterectomy for Known or Suspected Placenta Accreta Spectrum: A Cost-Effectiveness Analysis. BJOG. 2024. PMID: 39639523. doi:10.1111/1471-0528.18025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。